Sun Pharma Q3FY26 Revenue Up 15.1%, Interim Dividend Declared
Sun Pharmaceutical Industries reported a 15.1% YoY increase in revenue to ₹154,691 million for Q3FY26. Net profit rose by 16.0% to ₹33,688…
Birla Corporation Board Approves Q3 Results, Extends Key Personnel Terms
Birla Corporation’s Board approved the unaudited financial results for Q3 FY26, with standalone revenue at ₹1,197.94 Crores and a profit…
Sun Pharma Reports Q3FY26 Results, Interim Dividend Declared
Sun Pharmaceutical Industries Limited announced its Q3FY26 results with sales up by 15.1% YoY to ₹154,691 million. Net profit increased by…
Clean Science Q3 FY26 Results, Hydroquinone Production Begins
Clean Science and Technology Limited (CSTL) announced its Q3 FY26 results, showcasing resilient EBITDA margins amid challenging market…
Clean Science Declares Interim Dividend and Approves Q3 Results
Clean Science and Technology Limited announced the approval of its unaudited standalone and consolidated financial results for Q3 FY26. The…
Clean Science and Technology Declares Interim Dividend; Q3 Results Announced
Clean Science and Technology has announced its Q3 results and declared an interim dividend of ₹2/- per equity share. The company’s…
MOIL Limited JV Approval Received from Ministry of Steel
MOIL Limited has received approval from the Ministry of Steel for a Joint Venture (JV) agreement with Madhya Pradesh State Mining Corporation…
Vinati Organics Reports Q3 Results, Dividend & Policy Revisions
Vinati Organics Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company’s…
AstraZeneca Receives Approval for Durvalumab (Imfinzi) for Gastric Cancer Treatment
AstraZeneca Pharma India has received approval to import, sell, and distribute Durvalumab Solution for Infusion (120 mg/2.4 mL and 500 mg/10…
AstraZeneca Board Meeting Scheduled to Approve Unaudited Financial Results
AstraZeneca Pharma India Ltd. has announced a meeting of its Board of Directors on February 11, 2026, to consider and approve the unaudited…